Logo image of EVA.MI

ASKOLL EVA SPA (EVA.MI) Stock Fundamental Analysis

BIT:EVA - Euronext Milan - IT0005337123 - Common Stock - Currency: EUR

0.1295  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EVA. EVA was compared to 30 industry peers in the Automobiles industry. Both the profitability and financial health of EVA have multiple concerns. EVA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EVA had negative earnings in the past year.
EVA had a negative operating cash flow in the past year.
In the past 5 years EVA always reported negative net income.
In the past 5 years EVA always reported negative operating cash flow.
EVA.MI Yearly Net Income VS EBIT VS OCF VS FCFEVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

EVA has a worse Return On Assets (-25.87%) than 90.00% of its industry peers.
The Return On Equity of EVA (-135.17%) is worse than 93.33% of its industry peers.
Industry RankSector Rank
ROA -25.87%
ROE -135.17%
ROIC N/A
ROA(3y)-12.54%
ROA(5y)-14.94%
ROE(3y)-59%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
EVA.MI Yearly ROA, ROE, ROICEVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

EVA has a better Gross Margin (35.44%) than 83.33% of its industry peers.
EVA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.22%
GM growth 5Y-3.46%
EVA.MI Yearly Profit, Operating, Gross MarginsEVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The debt/assets ratio for EVA is higher compared to a year ago.
EVA.MI Yearly Shares OutstandingEVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2020 2021 2022 2023 5M 10M 15M 20M 25M
EVA.MI Yearly Total Debt VS Total AssetsEVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.05, we must say that EVA is in the distress zone and has some risk of bankruptcy.
EVA has a worse Altman-Z score (0.05) than 80.00% of its industry peers.
EVA has a Debt/Equity ratio of 2.34. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of EVA (2.34) is worse than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Altman-Z 0.05
ROIC/WACCN/A
WACC5.82%
EVA.MI Yearly LT Debt VS Equity VS FCFEVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.95 indicates that EVA should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.95, EVA is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
EVA has a Quick Ratio of 1.30. This is a normal value and indicates that EVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.30, EVA is in the better half of the industry, outperforming 76.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.3
EVA.MI Yearly Current Assets VS Current LiabilitesEVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

EVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -232.73%.
EVA shows a decrease in Revenue. In the last year, the revenue decreased by -4.88%.
EVA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.51% yearly.
EPS 1Y (TTM)-232.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.5%
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y-20.61%
Revenue growth 5Y-12.51%
Sales Q2Q%29.84%

3.2 Future

Based on estimates for the next years, EVA will show a very strong growth in Earnings Per Share. The EPS will grow by 23.43% on average per year.
EVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.77% yearly.
EPS Next Y73.13%
EPS Next 2Y33.83%
EPS Next 3Y23.43%
EPS Next 5YN/A
Revenue Next Year-10.71%
Revenue Next 2Y11.8%
Revenue Next 3Y14.77%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EVA.MI Yearly Revenue VS EstimatesEVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
EVA.MI Yearly EPS VS EstimatesEVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVA.MI Price Earnings VS Forward Price EarningsEVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVA.MI Per share dataEVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as EVA's earnings are expected to grow with 23.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.83%
EPS Next 3Y23.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASKOLL EVA SPA

BIT:EVA (6/2/2025, 7:00:00 PM)

0.1295

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.30M
Analysts42.86
Price Target0.07 (-45.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-64.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)60.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-26.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 1.8
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.11
BVpS0.07
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.87%
ROE -135.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.44%
FCFM N/A
ROA(3y)-12.54%
ROA(5y)-14.94%
ROE(3y)-59%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.22%
GM growth 5Y-3.46%
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.8%
Cap/Sales 5.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.3
Altman-Z 0.05
F-Score3
WACC5.82%
ROIC/WACCN/A
Cap/Depr(3y)14277.3%
Cap/Depr(5y)12488.9%
Cap/Sales(3y)12.75%
Cap/Sales(5y)13.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-232.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.5%
EPS Next Y73.13%
EPS Next 2Y33.83%
EPS Next 3Y23.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y-20.61%
Revenue growth 5Y-12.51%
Sales Q2Q%29.84%
Revenue Next Year-10.71%
Revenue Next 2Y11.8%
Revenue Next 3Y14.77%
Revenue Next 5YN/A
EBIT growth 1Y-345.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.32%
EBIT Next 3Y24.03%
EBIT Next 5YN/A
FCF growth 1Y-152.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18555.1%
OCF growth 3YN/A
OCF growth 5YN/A